IL-36 cytokine expression and its relationship with p38 MAPK and NF-κB pathways in psoriasis vulgaris skin lesions

Abstract

This study examined the correlation of the expression of interleukin-36 (IL-36), a novel member of interleukin-1 (IL-1) family, with p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor-kappa B (NF-κB) pathways in psoriasis vulgaris skin lesions. The expression levels of IL-36α, IL-36β, IL-36Γ, phosphorylated p38 MAPK, and NF-κBp65 were detected in the skin tissues of 38 psoriasis patients and 17 healthy control subjects by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting. The cytokine expression levels were compared between the psoriasis group and the control group. A correlation analysis between cytokine proteins was performed in the psoriasis group. Results showed that the expression levels of IL-36a, IL-36β, IL-36Γ, phosphorylated p38 MAPK and NF-κBp65 in the psoriasis group were significantly higher than those in the control group (P<0.001). In the psoriasis group, the IL-36 cytokine expression was positively correlated with phosphorylated p38 MAPK and NF-κBp65 expression (P<0.05). A significant positive correlation was also found between the phosphorylated p38 MAPK and NF-κBp65 expression (P<0.01). It was concluded that the increased IL-36 expression is correlated with p38 MAPK and NF-κB pathways in psoriasis vulgaris skin lesions. All the three factors may be jointly involved in the pathogenesis and local inflammatory response of psoriasis.

Keywords

interleukin-36 / p38 mitogen-activated protein kinase / nuclear factor-kappa B / psoriasis vulgaris

References

[1] NestleFO, KaplanDH, BarkerJ. Psoriasis. N Engl J Med, 2009, 361(5): 496-509

[2] ChristophersE. Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol, 2001, 26(4): 314-320

[3] HashimotoS, MatsumotoK, GonY, et al.. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells. Clin Exp Allergy, 2000, 30(1): 48-55

[4] HoldenNS, CatleyMC, CambridgeLM, et al.. ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. Eur J Biochem, 2004, 271(4): 785-791

[5] WuertzK, VoN, KletsasD, et al.. Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-κB and MAP kinases. Eur Cell Mater, 2012, 23: 103-119

[6] WangS, UchiH, HayashidaS, et al.. Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-kappaB p105/p50 in chronic inflammatory skin diseases. J Dermatol, 2009, 36(10): 534-540

[7] TowneJ, SimsJ. IL-36 in psoriasis. Curr Opin Pharmacol, 2012, 12(4): 486-490

[8] JohnstonA, XingX, GuzmanAM, et al.. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol, 2011, 186(4): 2613-2622

[9] EmingSA, KriegT, DavidsonJM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol, 2007, 127(3): 514-525

[10] NogralesKE, DavidoviciB, KruegerJG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg, 2010, 29(1): 3-9

[11] TowneJE, GarkaKE, RenshawBR, et al.. Interleukin(IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem, 2004, 279(14): 13677-13688

[12] SimsJE, SmithDE. The IL-1 family: regulators of immunity. Nat Rev Immunol, 2010, 10(2): 89-102

[13] BlumbergH, DinhH, TruebloodES, et al.. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med, 2007, 204(11): 2603-2614

[14] BlumbergH, DinhH, DeanCJr, et al.. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol, 2010, 185(7): 4354-4362

[15] CarrierY, MaHL, RamonHE, et al.. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol, 2011, 131(12): 2428-2437

[16] ZhangP, MartinM, MichalekSM, et al.. Role of mitogen- activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B. Infect Immun, 2005, 73(7): 3990-3998

[17] AlbanesiC, ScarponiC, GiustizieriML, et al.. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy, 2005, 4(3): 329-334

[18] BubiciC, PapaS, DeanK, et al.. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene, 2006, 25(51): 6731-6748

[19] HackerH, KarinM. Regulation and function of IKK and IKK-related kinases. Sci STKE, 2006, 2006(357): re13

[20] HaydenMS, GhoshS. Shared principles in NFkappaB signaling. Cell, 2008, 132(3): 344-362

[21] XiaoYQ, MalcolmK, WorthenGS, et al.. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem, 2002, 277(17): 14884-14893

[22] FecherLA, AmaravadiRK, FlahertyKT. The MAPK pathway in melanoma. Curr Opin Oncol, 2008, 20(2): 183-189

[23] YuXJ, LiCY, DaiHY, et al.. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol, 2007, 83(3): 413-418

[24] BellS, DegitzK, QuirlingM, et al.. Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal, 2003, 15(1): 1-7

[25] KaurJ, WoodmanRC, KubesP. P38 MAPK: critical molecule in thrombin-induced NF-kappa B-dependent leukocyte recruitment. Am J Physiol Heart Circ Physiol, 2003, 284(4): H1095-H1103